This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: The University of Chicago, University of Washington. Active years: 2007-2014.
Company Filing History:
4 out of 961 
4 out of 2,166 
Years Active: 2007-2014
Title: Brooke Bevis: Innovator in Fluorescent Protein Technology
Introduction
Brooke Bevis is a prominent inventor based in Somerville, MA (US). She has made significant contributions to the field of fluorescent proteins, with a total of 4 patents to her name. Her work focuses on rapidly maturing fluorescent proteins and their applications in various scientific fields.
Latest Patents
Among her latest patents is the invention titled "Rapidly maturing fluorescent proteins and methods for using the same." This patent includes nucleic acid compositions encoding rapidly maturing fluorescent proteins, as well as non-aggregating versions and their mutants. The proteins are characterized by their fluorescent properties, which arise from the interaction of specific residues within the protein structure. Additionally, her work includes monomeric red fluorescent proteins, which are variants of DsRed fluorescent proteins, along with methods for their use. These innovations have broad applications in research and biotechnology.
Career Highlights
Brooke Bevis has worked at prestigious institutions such as the University of Chicago and the University of Washington. Her research has significantly advanced the understanding and application of fluorescent proteins in various scientific disciplines.
Collaborations
Throughout her career, she has collaborated with notable colleagues, including Benjamin S. Glick and Daniel E. Strongin. These partnerships have contributed to her innovative work and the development of her patented technologies.
Conclusion
Brooke Bevis is a trailblazer in the field of fluorescent protein technology, with a strong portfolio of patents that reflect her innovative spirit and dedication to scientific advancement. Her contributions continue to impact research and applications in biotechnology.